Clinical Trial Update: Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of SPH3127 Tablets for diabetic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Drugs mentioned

• SPH3127 Tablets (SPH3127)

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: Diabetic Kidney Disease | Phase 2 | Status: COMPLETED